MHS

(redirected from RYR1)
Also found in: Medical, Financial, Acronyms.

MHS

MHS

(1) (Message Handling Service) An earlier messaging system from Novell that supported multiple operating systems and other messaging protocols, including SMTP, SNADS and X.400. It used the SMF-71 messaging format. Standard MHS ran on a DOS machine attached to the server, while Global MHS ran as a NetWare NLM. With NetWare 4, MHS was discontinued and superseded by GroupWise. See GroupWise.

(2) See messaging system.

(3) (MH/s) (Mega HASHes per SECond) One million hashes computed in one second. The term typically refers to cryptocurrency validation and mining. See cryptographic hash function and Bitcoin mining.
References in periodicals archive ?
Disorders caused by RYR1 mutations can share clinical features of both congenital myopathy and CMD.
RYR1 is well known as a meat quality gene and T allele is associated with reduced meat quality [28].
In response to heat, mutations in RYR1 cause excessive amounts of calcium to leak from the storage compartment and trigger uncontrolled muscle contractions.
Genotyping was done using a real-time PCR-based system (LightCycler, Roche, and Mannheim, Germany) with hybridization probes specific for the RYR1 C1843T SNP.
2+]] at the single cell level following exposure to the RYR1 activators caffeine, halothane and 4-CmC in conjunction with traditional CICR testing.
1), which roughly correspond to the RYR1 regions targeted by mutations causing malignant hyperthermia (MHS1; OMIM 145600) or central core disease (CCD; OMIM 117000) (14-29).
The accelerated group included two individuals carrying an RYR1 mutation and two patients who had experienced an MH episode (CGS 5-6).
Reports of discordance between mutations and IVCT phenotype have called into question the causal role of some RYR1 mutations (31-33), although the lack of specificity of the IVCT (34-37) or the presence of additional MH mutations (31, 37, 38) may account for some discrepancies.
Advances in analysis of the RYR1 gene (which encodes the skeletal muscle ryanodine receptor) show that genetic Examination is a useful adjunct to the in vitro contracture test in the diagnosis of malignant hypothermia, as defects in RYR1 have been shown to be responsible for malignant hyperthermia susceptibility.
If a patient does not have a familial mutation, does the research scientist then start screening the entire RYR1 gene for a second causative mutation, or is an IVCT immediately indicated?
Propofol has not been tested on cultured cells from the patients with RYR1 mutations.